Basal telomerase activity is dependent on expression of the hTERT and hTR genes and upregulation of telomerase gene expression is associated with tumour development. It is therefore possible that signal transduction pathways involved in tumour development and features of the tumour environment itself may influence telomerase gene regulation. The majority of solid tumours contain regions of hypoxia and it has recently been demonstrated that hypoxia can increase telomerase activity by mechanisms that are still poorly defined. Here, we show that hypoxia induces the transcriptional activity of both hTR and hTERT gene promoters. While endogenous hTR expression is regulated at the transcriptional level, hTERT is subject to regulation by alternative splicing under hypoxic conditions, which involves a switch in the splice pattern in favour of the active variant. Furthermore, analysis of the chromatin landscape of the telomerase promoters reveals dynamic recruitment of a transcriptional complex involving the hypoxia-inducible factor-1 transcription factor, p300, RNA polymerase II and TFIIB, to both promoters during hypoxia, which traffics along and remains associated with the hTERT gene as transcription proceeds. These studies show that hTERT and hTR are subject to similar controls under hypoxia and highlight the rapid and dynamic regulation of the telomerase genes in vivo.
Introduction
A major difference between cancer cells and their normal counterparts is the ability of cancer cells to grow and divide outwith normal cellular constraints in an unrestricted manner. The molecular events that lead to immortality and malignant transformation are beginning to be understood and a growing body of evidence points to a role for the ribonucleoprotein complex telomerase as a causative factor of immortalization in a large number of human cancers. However, despite numerous descriptions of telomerase expression within human tumours and cancer cell lines, the mechanisms of regulation are largely unknown. The complex biology of telomerase regulation from gene transcription to enzyme activity means that from a therapeutic standpoint telomerase provides not one but many potential targets, and a better understanding of the multiple levels at which telomerase can be regulated will allow many more targets to be realized.
The activation of telomerase is closely associated with tumour development. Therefore, it is possible that signal transduction pathways involved in tumour development may influence telomerase activity and gene regulation. Features of the tumour environment itself may also be responsible for the induction of gene expression. The majority of human solid tumours contain regions of hypoxia, which is caused by reduced oxygen delivery to the cells, due to poor diffusion and disruption of the microcirculation within the tumour mass. Hypoxia is associated with resistance to cancer therapeutics, increased genetic instability and enhanced malignant progression (Reynolds et al., 1996; Hockel and Vaupel, 2001) . Reactivation of telomerase in immortal cells and cancer tissues has been shown to prevent the genetic instability that ensues with telomere dysfunction and to reduce apoptosis (Seimiya et al., 1999; Gorbunova et al., 2002; Blasco and Hahn, 2003; Luiten et al., 2003) . Therefore, induced expression of telomerase under hypoxic conditions may be a selective advantage for tumour cell survival. Recently, it has been demonstrated that hypoxia can increase telomerase activity; however, the mechanisms by which this occurs are still poorly defined.
Both telomerase gene promoter sequences contain consensus hypoxia response element (HRE) sites, suggesting that telomerase could be regulated at the transcriptional level by direct binding of hypoxiainducible factor-1 (HIF-1). HIF-1 is an ab heterodimeric transcription factor that binds and regulates promoters containing the HRE motif. While the HIF-1b subunit is constitutively expressed, under normoxia the HIF-1a subunit is subject to prolyl hydroxylation, which targets this subunit for ubiquitinylation and subsequent proteasomal degradation (Ashcroft and Bardos, 2004) . Under hypoxia, however, HIF-1a degradation is inhibited leading to rapid induction of protein levels and formation of the functional heterodimer.
Focusing on the hTERT gene promoter, Yatabe et al. (2004) and Nishi et al. (2004) recently reported an increase in hTERT expression and transcriptional activity in response to hypoxia in choriocarcinoma and cervical carcinoma cell lines. In the present study, we extend these descriptions of telomerase gene regulation under hypoxia to both hTR and hTERT. We show that hypoxia induces remodelling of the transcriptional complexes associated with both gene promoters, which remain bound and traffic along the telomerase genes as transcription proceeds. Furthermore, we show a novel mechanism of hTERT gene regulation in the form of alternative splicing under hypoxic conditions, whereby increased hTERT expression is associated with a shift in the splicing pattern in favour of the active wild-type variant at the expense of the inactive b variant. Analysis of the promoters at the level of chromatin reveals the dynamic nature of telomerase gene regulation and shows that these genes are subject to similar regulatory controls in response to the hypoxic signal.
Results
Effect of overexpressing HIF-1a on expression from the telomerase gene promoters The limiting subunit of the HIF-1 transcription factor is the a subunit, which is subject to proteasomal degradation under normal oxidative conditions and is stabilized in hypoxia. Initially, in order to determine the effect of hypoxia on telomerase gene promoter activity in vitro, luciferase reporter constructs under the control of either hTR or hTERT promoter fragments were transiently cotransfected into the ovarian carcinoma cell line A2780 with a titration of CMV-HIF-1a expression vector. This has the effect of mimicking hypoxia by constitutive overexpression of the limiting subunit of HIF-1. After incubation for 48 h, cells were harvested for dual luciferase assay (Figure 1 ). hTR promoter activity was increased by at least twofold compared to vector alone ( Figure 1a) . Similarly, hTERT promoter activity was increased by up to threefold with HIF-1a compared to vector alone (Figure 1b) . Figure 1 Overexpression of HIF-1a induces telomerase gene expression. A2780 cells were transiently cotransfected with (a) hTR (pLh 2023) and (b) hTERT (pGL3 hTERT 24/9) reporter vectors along with a titration of the HIF-1a expression vector and pRL-SV40 as an internal control for transfection efficiency. Lane 1: vector alone; lane 2: vector þ 0.5 mg HIF-1a; lane 3: vector þ 1 mg HIF-1a; and lane 4: vector þ 1.5 mg HIF-1a. As a positive control for the hypoxic induction, A2780 cells were transiently transfected with a VEGF reporter vector (pLh VEGF) (c) alone (lane 1) or cotransfected with 1 mg HIF-1a (lane 2). Luciferase activity for 5 ml of cell lysate is expressed as fold induction compared to hTERT, hTR or VEGF vectors alone and corrected for Renilla. Results are the mean and standard errors of duplicate samples from three separate experiments. To confirm HIF-1a expression, A2780 ovarian carcinoma cells were transiently transfected with a titration of HIF-1a expression vector pcDNA-HIF-1a. After 48 h, cells were lysed using the Laemmli extraction buffer and Western blotting was carried out (d). Lanes 1 and 2: untreated A2780 extract; lanes 3 and 4: 0.5 mg HIF-1a; lanes 5 and 6: 1 mg HIF-1a; lanes 7 and 8: 1.5 mg HIF-1a; lane 9: CoCl 2 -treated Cos7 cell extract (active motif) as a positive control for HIF-1a expression.
As a positive control for the hypoxic response, a luciferase reporter construct under the control of the hypoxia-responsive vascular endothelial growth factor (VEGF) promoter was cotransfected with the HIF-1a expression vector. An eightfold induction of VEGF expression was seen with HIF-1a compared to vector alone ( Figure 1c) . As further confirmation of the hypoxic response, HIF-1a expression levels were determined by Western blot (Figure 1d ), which showed an increase in HIF-1a, levels with titration of the expression vector.
The induced expression from both telomerase gene promoters with over expression of HIF-1a suggests that hypoxia could play a role in telomerase gene regulation in the tumour environment.
Effect of hypoxia on endogenous expression of the telomerase genes In order to investigate whether hypoxia regulates endogenous telomerase gene expression, we performed semi-quantitative PCR on A2780 ovarian carcinoma cell extracts incubated under normal oxidative or hypoxic conditions over a time course between 2 and 10 h. Semi quantitative PCR for VEGF was used as a positive control for the hypoxic response. b-Actin was used as a loading control, as hypoxia has no effect on b-actin expression, whereas it causes an increase in the expression of GAPDH (Graven et al., 1994 ). An increase in VEGF expression was seen, which peaked at threefold induction compared to the untreated sample after 6 h of hypoxic treatment (Figure 2a ). Western blots for HIF1a showed that A2780 cells express HIF-1a at low levels, which increases with stabilization of the HIF-1a protein after just 2 h in hypoxia, confirming the hypoxic response ( Figure 2b ).
Endogenous hTR gene expression following hypoxic treatment analysed by semiquantitative PCR showed no notable change in the expression of hTR until after 6 h of hypoxic treatment when levels increased by around twofold compared to the untreated control ( Figure 2c ). This increase in expression was short lived, however, and had already begun to reduce again after 8 h of treatment.
In contrast to these observations, endogenous levels of total hTERT were unchanged by hypoxic treatment ( Figure 3a) ; however, it is known that hTERT is subject to regulation at the post-transcriptional level by alternative splicing (see Figure 6b ). In order to determine if alternative splicing could play a role in the regulation of hTERT expression under hypoxia, splice variant PCR was carried out using primers designed to detect the four major splice forms of hTERT. Figure 3b shows the active wild-type splice variant, which increases steadily with time in hypoxia. In contrast, the inactive b variant shows some increase after 2 h in hypoxia compared to the untreated control, but gradually decreases again over time (Figure 3c ). Taken as a percentage of total hTERT expression, a clear shift in splicing towards the active wild-type variant is seen with increased time in hypoxia ( Figure 3d ). This result suggests that, rather than simply increasing hTERT expression, hypoxia induces post-transcriptional regulation of hTERT gene expression, altering the ratio of splice variants in favour of the active form of the transcript. Determination of HIF-1 binding to the telomerase gene promoters Both telomerase gene promoters contain HRE sites, which are known to be required for HIF-1-induced transcriptional activation of hypoxia-responsive genes. We used chromatin immunoprecipitation (ChIP) assays for the limiting HIF-1a subunit to investigate association of HIF-1 with sequences within the hTR and hTERT promoters in vivo. A2780 ovarian carcinoma cells were incubated for 6 h under hypoxic or normoxic conditions. Hypoxic treatment (6 h) was selected for this and subsequent ChIP experiments as a time when induction of both hTR and hTERT expression was achieved (see Figures 2 and 3) . Following incubation, cells were immediately fixed and ChIP carried out. As shown in Figure 4 , some HIF-1a is associated with the hTR, hTERT and VEGF promoters in normoxia, but is increased following 6 h in hypoxia. This is in agreement with previous Western blot results for HIF1a showing low expression of HIF-1a in untreated cell extracts and protein stabilization after hypoxic treatment (Figure 2b ). Semiquantitative PCR for the hTR promoter reveals a threefold increase in association of HIF-1a subsequent to hypoxic treatment (Figure 4a) . A similar pattern of association is seen in PCR for the hTERT promoter, with a twofold increase following hypoxia. Interestingly, HIF-1a association was also detected at downstream intragenic sites. Semiquantitative PCR for exon 12 of hTERT, which is around 38 kbp downstream, shows association of HIF-1a in untreated Figure 3 Hypoxia has no effect on overall endogenous hTERT expression levels, but induces alternative splicing of the hTERT transcript. A2780 cells were incubated under normoxic conditions (untreated) or hypoxic conditions and RNA extracted after 2, 4, 6, 8 and 10 h of treatment. cDNA was synthesized using 1 mg RNA. Semiquantitative PCR for hTERT splice variants using primers that detect all four major splicing variants of the hTERT transcript was corrected for b-actin expression. PCR products were quantified using the Agilent Bioanalyser. cells is increased in hypoxia (Figure 4b ). In addition, a similar increase in association of HIF-1a is seen in association with the hypoxia-responsive VEGF gene promoter (Figure 4c ), which is known to bind HIF-1 via the consensus HRE sequence (Forsythe et al., 1996) .
Characterization of the transcriptional complex associated with the telomerase genes under hypoxic conditions HIF-1 is known to bind to the promoters of a variety of genes, where it recruits the basal transcriptional machinery and transcriptional coactivators such as the p300/CREB-binding protein (CBP) complex to induce transcription. In order to build a picture of the transcriptional complex associated with the telomerase genes, alongside HIF-1a, following hypoxic treatment, ChIP was carried out to detect the presence of the general transcriptional machinery components RNA polymerase II and TFIIB, in addition to the transcriptional coactivator p300. ChIP assays revealed basal association of RNA polymerase II with both hTR and hTERT promoters in untreated A2780 cells. RNA polymerase II levels increased more than sixfold for hTR and marginally for hTERT (o2-fold) following 6 h in hypoxia (Figure 5a and b) .
Another major component of the basal transcriptional machinery is TFIIB, one of the roles of which is stabilization of the transcriptional complex. At the hTR promoter there is very little TFIIB associated with the promoter, before hypoxic treatment. However, TFIIB levels increased more than twofold in response to hypoxia ( Figure 5a ). As observed for Pol II, TFIIB is present at the hTERT promoter prior to hypoxic treatment and association is increased subsequent to hypoxic treatment (Figure 5b ). The transcriptional coactivator p300 is known to be associated with hypoxia-inducible gene expression. Consistent with known information for other genes, p300 is found associated with both hTR and hTERT promoters only after hypoxic treatment (Figure 5a and b, lanes 5 and 6) .
Interestingly, a pattern of association similar to that found at the hTERT promoter was also seen at exon 12 (Figure 5c ). Although RNA polymerase II levels remain virtually unchanged following hypoxic treatment (Figure 5c ), TFIIB levels are increased by threefold (Figure 5c ) and, as seen at the promoter, p300 is only associated with exon 12 after hypoxia (Figure 5c , lanes 5 and 6). As mentioned previously, increased levels of HIF-1a are also found associated with exon 12 after treatment. The presence of transcriptional machinery components within gene coding regions has previously been correlated with active gene transcription (Zhang et al., 2003b) ; therefore, the results presented here suggest that hTERT is being actively transcribed under hypoxic conditions and that the transcriptional complex remains bound to the gene as transcription proceeds.
To investigate how these alterations in the recruitment of the basal transcriptional machinery at the telomerase gene promoters in response to hypoxia compared to those associated with a known hypoxia-responsive gene, semiquantitative PCR for the VEGF promoter was utilized. Figure 5d shows a similar pattern of association of RNA polymerase II and TFIIB in untreated cells, and the subsequent increased association in response to hypoxia, as was visualized at both telomerase gene promoters. As expected, p300 also specifically associates with the VEGF promoter following hypoxic-treatment. Interaction of p300 with hypoxia responsive gene promoters has previously been shown using electromobility gel shift assays; however, this is the first time that p300 has been shown to interact with hypoxiaresponsive gene promoters in vivo.
Discussion
This study emphasizes the importance of the tumour microenvironment on the regulation of telomerase gene expression. It has previously been shown that hypoxia can upregulate telomerase activity (Seimiya et al., 1999; Minamino et al., 2001) , and recent studies focusing on the hTERT promoter show that this upregulation is correlated with increased transcriptional activation of hTERT through the specific activities of the HIF-1 transcription factor Yatabe et al., 2004) . The data presented here show that both telomerase genes are dynamically regulated under hypoxic conditions and that gene expression is associated with the recruitment of a hypoxia-responsive transcriptional complex, which remains associated with and traffics along the genes as transcription proceeds. Furthermore, we identify a novel mechanism of hTERT regulation whereby, rather than simply increasing total hTERT expression, hypoxia induces alternative splicing, with a switch in the ratios of spliced transcripts in favour of the active wild-type variant.
Dual luciferase assays for cotransfection of telomerase promoter containing vectors with an HIF-1a expression vector mimicking hypoxia showed specific induction of activity from both telomerase gene promoters with HIF-1a compared to vector alone. A similar induction of hTERT promoter activity with cotransfection of an HIF-1a expression vector was previously shown; however, the effect of hypoxia on expression from the hTR promoter is shown here for the first time. An increase in promoter activity in response to HIF-1a overexpression would suggest that regulation of telomerase gene expression by hypoxia occurs at the transcriptional level. In accordance with this, steadystate levels of hTR RNA were increased after 6 h of hypoxic treatment, but this increase was transient and levels had begun to reduce again after 8 h of hypoxic treatment. Interestingly, no change in overall levels of hTERT mRNA were seen in A2780 cells at the times tested, consistent with the results of Seimiya et al. (1999) . An increase has been documented for other cell types between 6 and 12 h of hypoxic treatment Yatabe et al., 2004) , which may suggest a cell-type-specific regulation; however, none of these studies addressed the issue of alternative splicing of hTERT.
hTERT activity is known to be regulated at the posttranscriptional level by differential splicing (Figure 6b ) (Kilian et al., 1997; Ulaner et al., 1998) . Although the mechanism and function of hTERT alternative splicing is unknown at present, the pattern of splice variants in human foetal liver was demonstrated to be altered during development to leave just the inactive b variant expressed after 17 weeks gestation, correlating with loss of telomerase activity (Ulaner et al., 1998) , which suggests that differential splicing of hTERT could be a means of regulating gene expression without altering overall transcription levels under certain conditions. The switch in the ratios of the hTERT splice variants in favour of the active wild-type variant, revealed here in response to hypoxia, correlate with increased promoter activity in cotransfection with HIF-1a. There are many examples of differential splicing of genes induced by stress that result in changed activity (Hashimoto et al., 2002; Munch et al., 2003; Romero-Ramirez et al., 2004) and we can now add hTERT to this list.
Accumulating evidence suggests that splicing mechanisms may be linked to transcription. Several mechanisms, such as exon skipping, have been proposed to explain how differential splicing occurs (Kornblihtt et al., 2004) . Although it is still unclear if splicing is an active mechanism of hTERT gene regulation or has some other accessory role, it is interesting to find that other gene promoters may also be regulated at this level. Transcriptional coactivators, such as NCoA62/SKIP in association with the Vitamin D receptor (Zhang et al., 2003a) and RNA polymerase II itself (Misteli, 1999) , have been shown to associate with components of the spliceosome and splicing has been correlated with increased promoter activity. The hTERT promoter has a long transcriptional start site with no TATA box and is weak in terms of transcriptional activity, especially in comparison with hTR (Plumb et al., 2001; Bilsland et al., 2003) ; therefore, it could be that hypoxic induction of this weak promoter leads to more efficient splicing, perhaps through increased association with the transcriptional machinery.
Under hypoxic conditions, binding of the HIF-1 transcription factor initiates formation of a large multisubunit transcriptional complex on hypoxia-responsive gene promoters. An increased association of the limiting a subunit of HIF-1, RNA polymerase II and TFIIB was demonstrated by ChIP after hypoxic treatment at both telomerase gene promoters and the known hypoxiaresponsive gene, VEGF. TFIIB plays an important role in the formation of the preinitiation complex, acting as a bridge between TBP and RNA Pol II and ensuring correct positioning of RNA Pol II over the transcriptional start site (Chen and Hahn, 2004; Elsby and Roberts, 2004; Hahn, 2004) ; therefore, an increase in TFIIB association may increase the stability of the transcriptional complex, ensuring more efficient transcription of the telomerase genes in response to hypoxic treatment.
The homologous transcriptional coactivators CREBbinding protein (CBP) and p300 form part of this transcriptional complex under hypoxic conditions when they are recruited to HIF-1 via an interaction between the C-terminal activation domain of HIF-1a and the C/H1 region (cysteine/histidine-rich 1) of p300 (Arany et al., 1996; Kallio et al., 1998; Kung et al., 2000; Freedman et al., 2002) . Consistent with this p300 is specifically associated with hTR, hTERT and VEGF gene promoters after hypoxic treatment. Taken together, these data suggest the presence of a hypoxiainducible transcriptional complex on the telomerase gene promoters, involving the basic transcriptional machinery in association with HIF-1 and the coactivator p300/CBP. Further investigation with the use of RNA interference technology may highlight potential roles for the ordered recruitment of transcriptional complex components in alternative splicing of hTERT under hypoxic conditions (Shi et al., 2003) .
Association of RNA polymerase II with gene coding regions has been shown to coincide with active gene transcription (Zhang et al., 2003b) , as opposed to its presence at the promoter region where it could be stalled. Therefore, it was of interest to observe the transcriptional complex in association with hTERT at exon 12, in addition to the promoter region. As exon 12 is over 38 kbp downstream of the promoter (Figure 6a) , this confirms the active transcription of this gene under hypoxic conditions. Taking hTERT as a example, these observations allow a model of the transcriptional regulation of the telomerase gene promoters under conditions of hypoxia in vivo to be proposed (Figure 6c) , in which the basal transcriptional machinery, in addition to the transcriptional coactivator p300, is recruited to the promoter by HIF-1 in response to the hypoxic signal and seen to traffic along the gene and remain associated as transcription proceeds.
A greater understanding of the mechanisms regulating telomerase gene expression is necessary in order to make best use of the telomerase gene promoters in the treatment of diseases such as cancer where hypoxia is a prevalent factor. These findings provide further evidence that the telomerase genes are regulated in vivo at the level of the chromatin environment and could have implications for telomerase-driven therapeutics, such as gene therapy strategies where the efficacy and specificity of treatment may be improved with increased telomerase gene expression under hypoxia. In addition, the increase in full-length transcripts of hTERT under hypoxic conditions offers another potential target for antitelomerase therapeutics (Zaffaroni et al., 2002) .
Materials and methods
Cell culture A2780 ovarian adenocarcinoma cells were maintained in RPMI 1640 growth medium supplemented with 10% foetal calf serum at 371C in the presence of 5% CO 2 . For hypoxic treatment, cells were cultured in 5% CO 2 in 95% N 2 within a modular incubator chamber (Billups-rotherberg Inc.).
Transfection and luciferase reporter assays Cells were seeded into six-well plates at a concentration sufficient to give 60-80% confluency on the day of transfection, typically 4 Â 10 5 cells/well, and cultured overnight. In all, 3 mg hTERT, hTR or VEGF reporter plasmids were cotransfected with 0.5-1.5 mg HIF-1a expression vector and 0.5 mg pRL-SV40 as an internal control for transfection efficiency using Superfect transfection reagent (Qiagen) following the manufacturer's instructions. After a 48 h incubation, cells were analysed for both Firefly and Renilla luciferase expression using the Dual Luciferase Assay system (Promega). All transfections were carried out in duplicate and corrected for Renilla expression. Results presented are the means of at least three independent experiments. The fidelity of pRL-SV40 as an internal control for transfection efficiency was confirmed by cotransfection of pGL3 control, containing the SV40 promoter, with a titration of HIF-1a prior to use to determine any effects on SV40 promoter expression.
Western blot A2780 cells were incubated in hypoxia for a time course between 2 and 10 h and protein was extracted from hypoxic treated and untreated cells using 2 Â Laemmli quick lysis extraction buffer (4% SDS, 10% glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue, 1.25 mM Tris-HCl, pH 6.8), 250 ml per 10 cm plate. A measure of 50 ml lysate was electrophoresed on a 10% SDS-polyacrylamide gel and transferred to nitrocellulose membranes. Membranes were incubated with specific antibodies against HIF-1a (sc-13515, Santa Cruz Biotechnology or 610958, BD Transduction Labs) followed by a horse-radish-peroxidase-conjugated species-specific secondary antibody. Immunoreactive bands were detected using the ECL detection system (Amersham Bioscience) as per manufacturer's instructions.
PCR
Total RNA was isolated from hypoxic-treated and -untreated cells using the NucleoSpin RNA II kit (Macherey-Nagel GmbH & Co. KG) as per the manufacturer's instructions. cDNA was synthesized from 1 mg RNA using the GeneAmp RNA PCR core kit (Roche) and the integrity of the synthesis was assessed by performing PCR for b-actin using the Taq PCR core kit (Qiagen) and primers 5 0 : ATCTGGCACCAC ACCTTCTACAATGGCTGCG and 3 0 : CGTCATACTCCT GCTTGCTGATCCACATCTGC (Clontech).
Semiquantitative PCR for hTERT splice variants was carried out using the Taq PCR core kit using HotStar Taq polymerase (Qiagen) and HT2026F: GCC TGA GCT GTA CTT TGT CAA and HT2482R: CGC AAA CAG CTT GTT CTC CAT GTC primers, which detect all four major splice variants of hTERT. Similarly, semiquantitative PCR for VEGF expression was carried out using the Taq PCR core kit (Qiagen) with VEGF F1: GGC CTT CGC TTA CTC TCA CC and VEGF R1: CAG GGA GAG AGA GAT TGG AA primers. PCR products were amplified from 1 ml cDNA, corrected for b-actin expression as a loading control and quantified using the Agilent 2100 BioAnalyser and DNA 1000 Chips (Agilent Technologies).
Semiquantitative PCR for hTR expression and chromatin immunoprecipitation was carried out using the DyNAmo SYBR green qPCR kit (Finnzymes) and Opticon 2 DNA Engine from MJ Research. All reactions were set up in triplicate and no DNA control in addition to a known concentration range of a DNA standard expressing the product of interest were also set up in triplicate. Reactions were performed for 1 ml of each sample using the primers documented below: hTR expression TRC3F, CTA ACC CTA ACT GAG AAG GGC GTA and TRC3R, GGC GAA CGG GCC AGC AGC TGA CAT T; hTR ChIP HTR29SF, CCC GCC CGA GAG AGT GAC and HTR5ALTR, AAG TCA GCG AGA AAA ACA GC; hTERT ChIP TERTfs, TCC CCT TCA CGT CCG GCA TT and TERTrs, AGC GGA GAG AGG TCG AAT CG; hTERT exon 12 ChIP Ex12 Fa, CAG GAC AAG GAA GCG GGA GGA A and Ex12 Rab, CAG CCG CAA GAC CCC AAA GA; VEGF ChIP VEGFprF, GTA GGT TTG AAT CAT CAC GCA GG and VEGFprR, GCA CCA AGT TTG TGG AGC TGA.
Chromatin immunoprecipitation
ChIP was carried out according to the protocol of GomezRoman et al. (2003) . Briefly, cells incubated either in hypoxia or normoxia were crosslinked for 10 min in 1% neutralbuffered formaldehyde rinsed briefly and scraped in PBS/NP40 (0.5%). Cell pellets were subjected to hypertonic and hypotonic lysis and extracted nuclei were lysed in 20% sarkosyl and passed through two sucrose gradients to purify chromatin. Samples were sonicated to yield chromatin fragments between 200 and 600 bp and immunoprecipitated overnight using antibodies to HIF-1a (ab-2185, Abcam), RNA Polymerase II (sc-899, Santa Cruz Biotechnology), TFIIB (sc-225, Santa Cruz Biotechnology) and p300 (554215, BD Pharmingen). A no-antibody control sample was included as a negative control for the immunoprecipitation to detect non-specific binding and any background was subtracted as necessary (Atkinson et al., 2005) . Immunoprecipitated chromatin was recovered using protein G agarose beads. Following several wash steps of increasing ionic strength, protein and antibodies were degraded by incubation with Proteinase K and DNA was purified twice with phenol/chloroform/isoamylalcohol and once with chloroform, then ethanol precipitated at À201C overnight. PCR for the purified immunoprecipitates was carried out as described above. Samples were expressed as a percentage of the input chromatin fraction.
